Letter: loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease-authors' reply
Aliment Pharmacol Ther
.
2022 Feb;55(4):499-500.
doi: 10.1111/apt.16757.
Authors
Remi Mahmoud
1
,
Johannes P D Schultheiss
1
,
Herma H Fidder
1
,
Bas Oldenburg
1
Affiliation
1
Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands.
PMID:
35092052
DOI:
10.1111/apt.16757
No abstract available
Publication types
Letter
Comment
MeSH terms
Chronic Disease
Duration of Therapy*
Humans
Inflammatory Bowel Diseases* / drug therapy